Time Restricted Eating Plus Exercise for Weight Management
1 other identifier
interventional
36
1 country
1
Brief Summary
Time restricted eating (TRE) is currently the most popular form of intermittent fasting which involves confining the eating window to 8-10 hours (h) and fasting for the remaining hours of the day. TRE is unique in that during the eating window, individuals are not required to count calories or monitor food intake in any way, resulting in high adherence. Accumulating evidence suggests that TRE produces a natural energy deficit of \~350-500 kcal/d. Physical activity in combination with a healthy diet pattern is recommended for older adults. While aerobic type exercise is the most commonly recommended, retention of lean mass via resistance training, especially in older adults, may be more effective at improving mobility, neurological and psychological function, executive and cognitive functioning, and processing speed. TRE combined with physical activity has not been examined in older adults or in people with overweight or obesity. This study holds the potential to 1) decrease body weight 2) improve lean mass 3) improve insulin sensitivity, and 4) improve attention, executive functioning, and processing speed in older adults. The aims of this study will examine the effect of TRE combined with either resistance training or aerobic training on body weight, body composition, metabolic disease risk, and cognition in adults over age 50. It is hypothesized that the TRE combined with resistance training group will see the most significant improvements in body composition, insulin sensitivity and cognition due to lean mass accretion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2022
CompletedFirst Posted
Study publicly available on registry
March 22, 2022
CompletedStudy Start
First participant enrolled
September 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2024
CompletedSeptember 26, 2024
September 1, 2024
10 months
March 11, 2022
September 24, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Lean mass
fat free mass will be measured via DXA
change from week 1 to week 12
Secondary Outcomes (9)
body weight
change kg of body weight from week 1 to week 12
fat mass
change kg of body weight from week 1 to week 12
Visceral fat mass
change kg of body weight from week 1 to week 12
Insulin
change from week 1 to week 12
glucose
change from week 1 to week 12
- +4 more secondary outcomes
Study Arms (2)
TRE+RT
EXPERIMENTALParticipants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised resistance training per week.
TRE+AT
ACTIVE COMPARATORParticipants will confine eating between either 10am-6pm or 12-8pm and fast from 6pm-10am or 8pm-12pm daily combined with 3-4 days of supervised aerobic training per week.
Interventions
We will compare the effects of TRE combined with resistance exercise versus TRE combined with aerobic training. Other Names: resistance training endurance exercise
Eligibility Criteria
You may qualify if:
- Adults with obesity (BMI between 30-50kg/m2)
- pre-diabetes (fasting glucose: 100-125 mg/dl or HBA1c 5.7%-6.4% or OGTT ≥ 200 mg/dl)
- sedentary or lightly active (\<7,500 steps/day)
- between the ages of 50-80 years
You may not qualify if:
- diagnosed with T1DM or T2DM (fasting glucose: \>126 mg/dl, 2-h glucose OGTT ≥ 200 mg/dl,
- HbA1c: \>6.5%)
- Individuals with a history of eating disorders
- shift workers
- Individuals taking drugs to control body weight and glucose (including metformin)
- individuals who are not weight stable (weight gain or loss \> 4 kg) 3 months prior to the intervention
- mobility disorders or individuals unable to exercise for 40-60 minutes 3-4 days/week
- Individuals diagnosed with comorbidities impacting cognition, including major/mild neurocognitive disorder, cerebrovascular disease (e.g., stroke, aneurysm, arteriovenous malformation), traumatic brain injury, epilepsy, or major psychiatric disorder (e.g., schizophrenia, bipolar disorder, substance use disorder)
- Individuals who are unable to adequately report dietary intake or physical activity
- Smokers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- blood sample analysis will be blinded
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor and Postdoctoral Researcher
Study Record Dates
First Submitted
March 11, 2022
First Posted
March 22, 2022
Study Start
September 21, 2023
Primary Completion
July 18, 2024
Study Completion
July 18, 2024
Last Updated
September 26, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share